M
MGX
Metagenomi Therapeutics, Inc
1.360
+0.010+0.74%After Hours: 1.360 0.000 0.00%16:10 05/26 EDT
OPEN/PREV CLOSE1.330/1.360
TODAY RANGE1.310-1.420
VOL240.84K
MARKET CAP52.33M
52 WEEK RANGE1.240-3.950
AVG VOL (3M)211.26K
% TURNOVER0.64%
TURNOVER--
P/E (TTM)-0.6053
% RANGE8.09%
EPS(TTM)-2.2965
P/E(FORWARD)-0.6588
P/B0.3798
BVPS3.660
DIVIDEND--
P/S2.074
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP42.25M
SHARES OUTSTANDING37.65M
NEXT EARNINGS08/10-08/14
FREE FLOAT30.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/14 13:33
Analysts Have Lowered Expectations For Metagenomi Therapeutics, Inc. (NASDAQ:MGX) After Its Latest Results
Dow Jones·05/12 13:37
Metagenomi Price Target Cut to $9.00/Share From $12.00 by Wells Fargo
Dow Jones·05/12 13:37
Metagenomi Is Maintained at Overweight by Wells Fargo
TipRanks·05/12 10:38
Wells Fargo Keeps Their Buy Rating on Metagenomi, Inc. (MGX)
TipRanks·05/12 10:27
Metagenomi price target lowered to $9 from $12 at Wells Fargo
Reuters·05/12 07:21
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
TipRanks·05/11 20:47
Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy
TipRanks·05/11 20:36
Metagenomi reports Q1 EPS (61c), consensus (55c)
Reuters·05/11 20:05
METAGENOMI THERAPEUTICS INC - Q1 NET LOSS PER SHARE $0.61
Dow Jones·05/11 20:05
Press Release: Metagenomi Therapeutics Reports -2-
Barchart·05/11 15:18
Metagenomi Therapeutics: Q1 Earnings Snapshot
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.